{"id":16689,"date":"2026-10-21T19:01:56","date_gmt":"2026-10-21T13:31:56","guid":{"rendered":"https:\/\/goldenpi.com\/blog\/?p=16689"},"modified":"2026-10-21T19:02:12","modified_gmt":"2026-10-21T13:32:12","slug":"sun-pharma-to-raise-10000-crore-through-bonds-to-part-finance-organon-acquisition","status":"publish","type":"post","link":"https:\/\/goldenpi.com\/blog\/bond-news\/sun-pharma-to-raise-10000-crore-through-bonds-to-part-finance-organon-acquisition\/","title":{"rendered":"Sun Pharma to Raise \u20b910,000 Crore Through Bonds to Part-Finance Organon Acquisition"},"content":{"rendered":"
\n
\ud83d\udcdd Quick Summary:<\/div>\n

<\/span>Sun Pharma is lining up a \u20b910,000 crore rupee bond issue to repay part of the roughly $12 billion bridge loan for Organon, sources told Reuters. The deal, expected to close by early 2027, would be its largest acquisition.<\/strong><\/span><\/h2>\n<\/div>\n\n\n

Sun Pharma\u2019s all-cash Organon acquisition is valued at $11.75 billion, including debt. More than $10 billion of it is being funded by a syndicate of 11 banks plus the three original underwriters, with the rest coming from the company\u2019s own cash. The rupee bonds would add a domestic funding route.\u00a0<\/p>

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n